Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$27,289,099
+$4,239,292 QoQ
Shares Held
108,445
+2.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#516
of 4,153 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TIAA Wealth Investment Management LLC holds $132,046,216 across 13 Drug Manufacturers - General names. ABBV ranks #3 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,205 | $42,225,935 | |
| 2 | JNJ |
Johnson & Johnson
|
127,432 | $32,363,905 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
108,445 | $27,289,099 | |
| 4 | MRK |
Merck & Co., Inc.
|
176,857 | $22,726,124 | |
| 5 | AMGN |
Amgen Inc
|
6,827 | $2,472,192 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,957 | $1,131,627 | |
| 7 | PFE |
Pfizer Inc
|
45,520 | $1,096,121 | |
| 8 | NVO |
Novo Nordisk A S
|
22,279 | $1,068,054 |
All Filings in ABBV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,289,099 | 108,445 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $23,049,807 | 105,981 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||